checkAd
    Startseite > Aktien > Gensight Biologics > Nachrichten
    Gensight Biologics Aktie
    0,4160
     
    EUR
    +2,09 %
    +0,0085 EUR
    Letzter Kurs 24.04.24 Tradegate
    0,4210
     
    EUR
    7.130 STK
    Geldkurs 12:10:13
    0,4260
     
    EUR
    7.050 STK
    Briefkurs 12:10:13
    ISIN: FR0013183985 · WKN: A2ANGZ · SYM: G49N · Frankreich

    Neueste Nachrichten

    GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
    18.04.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Reports Cash Position as of March 31, 2024, and Provides Business Update
    04.04.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Announces its 2024 Financial Calendar
    04.04.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Reports Full Year 2023 Consolidated Financial Results
    22.03.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ Injections Four Years After One-Time Administration
    20.03.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ Gene Therapy at NANOS 2024
    12.03.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ Gene Therapy at NANOS 2024
    06.03.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Announces LUMEVOQ Scientific Updates at NANOS 2024
    04.03.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics announces completion of a €5 million capital increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital
    08.02.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Reports Cash Position as of December 31, 2023, and Provides Business Update
    25.01.24 · Business Wire (engl.) · Gensight Biologics
    Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company’s Board of Directors
    16.01.24 · Business Wire (engl.) · Gensight Biologics
    GenSight Biologics Provides Business and Financial Update
    27.12.23 · Business Wire (engl.) · Gensight Biologics